✦ LIBER ✦

Familial Haploidentical (FHI) T-Cell Depleted (TCD) with T-Cell Addback Stem Cell Transplantation for Patients with High-Risk Sickle Cell Disease (SCD) (IND 14359)

✍ Scribed by Talano, Julie-An; Keever-Taylor, Carolyn; Walters, Mark; Shenoy, Shalini; Moore, Theodore B.; Parsons, Susan K.; Abikoff, Cori; Dozor, Allen J.; Friedman, Deborah; Chitti, Ramanamoorthy; Shi, Qiuhu; Grossman, Brenda; Weinberg, Rona; Morris, Erin; Brand, Phyllis; Mangan, Daniel; Foley, Sandra; Militano, Olga; Ayello, Janet; Semidei-Pomales, Mildred; Baxter-Lowe, Lee Ann; Cairo, Mitchell S.

Book ID: 122130774
Publisher: Elsevier Science
Year: 2014
Tongue: English
Weight: 511 KB
Volume: 20
Category: Article
ISSN: 1083-8791
DOI: 10.1016/j.bbmt.2013.12.208

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Familial Haploidentical (FHI) T-Cell Dep

Familial Haploidentical (FHI) T-Cell Depleted (TCD) Transplantation in High-Risk Sickle Cell Disease (IND 14359)

✍ K. Radhakrishnan; J.-A. Talano; C. Keever-Taylor; M. Bhatia; S. Shenoy; M. Walte 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 77 KB

T Cell–Depleted Stem Cell Transplantatio

T Cell–Depleted Stem Cell Transplantation for Adults with High-Risk Acute Lymphoblastic Leukemia: Long-Term Survival for Patients in First Complete Remission with a Decreased Risk of Graft-versus-Host Disease

✍ Goldberg, Jenna D.; Linker, Alex; Kuk, Deborah; Ratan, Ravin; Jurcic, Joseph; Ba 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 517 KB

Feasibility of Low Dose Azacitidine Post

Feasibility of Low Dose Azacitidine Post T Cell Depleted Allogeneic Hematopoietic Stem Cell Transplants in Patients with Myeloid Malignancies At High Risk for Relapse

✍ Tamari, Roni; Ponce, Doris; Jakubowski, Ann A.; Giralt, Sergio A.; Young, James; 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 53 KB

Reduced-intensity conditioning followed

Reduced-intensity conditioning followed by T-cell depleted allogeneic stem cell transplantation for patients with chronic myeloid leukaemia and minimal residual disease at the time of transplant: high risk of molecular relapse

✍ Mark Ringhoffer; Stephanie von Harsdorf; Michael Schmitt; Markus Wiesneth; Thors 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 463 KB

A Pilot Study of T-Cell Depleted Allogen

A Pilot Study of T-Cell Depleted Allogeneic Hematopoietic Stem Cell Transplantation With Busulfan, Melphalan, and Fludarabine Conditioning Followed by Post Transplantation Donor Lymphocyte Infusions for Patients With Relapsed Multiple Myeloma and High-Risk Cytogenetics

✍ G. Koehne; H. Landau; H. Hassoun; A. Lesokhin; N. Lendvai; M. Rosenzweig; D.J. C 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 55 KB

A survey of fully haploidentical hematop

A survey of fully haploidentical hematopoietic stem cell transplantation in adults with high-risk acute leukemia: a risk factor analysis of outcomes for patients in remission at transplantation

✍ Ciceri, F.; Labopin, M.; Aversa, F.; Rowe, J. M.; Bunjes, D.; Lewalle, P.; Nagle 📂 Article 📅 2008 🏛 American Society of Hematology 🌐 English ⚖ 505 KB